Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
Rivas L, Alcalde-Rico M, Martínez JRW, Moreno MV, Rojas P, Wozniak A, García P, Olivares-Pacheco J, Miller WR, Arias CA, Khan A, Munita JM. Rivas L, et al. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0165721. doi: 10.1128/AAC.01657-21. Epub 2021 Nov 15. Antimicrob Agents Chemother. 2022. PMID: 34780269 Free PMC article.
A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.
Khan A, Rivas LM, Spencer M, Martinez R, Lam M, Rojas P, Porte L, Silva F, Braun S, Valdivieso F, Mv Lhauser M, Lafourcade M, Miller WR, García P, Arias CA, Munita JM. Khan A, et al. Among authors: rivas lm. J Clin Microbiol. 2019 Aug 26;57(9):e00798-19. doi: 10.1128/JCM.00798-19. Print 2019 Sep. J Clin Microbiol. 2019. PMID: 31315958 Free PMC article.
Correction for Khan et al., "A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage".
Khan A, Rivas LM, Spencer M, Martinez R, Lam M, Rojas P, Porte L, Silva F, Braun S, Valdivieso F, Mϋlhauser M, Lafourcade M, Miller WR, García P, Arias CA, Munita JM. Khan A, et al. Among authors: rivas lm. J Clin Microbiol. 2021 May 19;59(6):e00734-21. doi: 10.1128/JCM.00734-21. Print 2021 May 19. J Clin Microbiol. 2021. PMID: 34011617 Free PMC article. No abstract available.
Isolation of Ciprofloxacin and Ceftazidime-Resistant Enterobacterales From Vegetables and River Water Is Strongly Associated With the Season and the Sample Type.
Díaz-Gavidia C, Barría C, Rivas L, García P, Alvarez FP, González-Rocha G, Opazo-Capurro A, Araos R, Munita JM, Cortes S, Olivares-Pacheco J, Adell AD, Moreno-Switt AI. Díaz-Gavidia C, et al. Among authors: rivas l. Front Microbiol. 2021 Sep 14;12:604567. doi: 10.3389/fmicb.2021.604567. eCollection 2021. Front Microbiol. 2021. PMID: 34594307 Free PMC article.
Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
Contreras-Gómez MJ, Martinez JRW, Rivas L, Riquelme-Neira R, Ugalde JA, Wozniak A, García P, Munita JM, Olivares-Pacheco J, Alcalde-Rico M. Contreras-Gómez MJ, et al. Among authors: rivas l. Front Pharmacol. 2022 Oct 3;13:1007162. doi: 10.3389/fphar.2022.1007162. eCollection 2022. Front Pharmacol. 2022. PMID: 36263116 Free PMC article.
Dynamics of the MRSA Population in a Chilean Hospital: a Phylogenomic Analysis (2000-2016).
Martínez JRW, Planet PJ, Spencer-Sandino M, Rivas L, Díaz L, Moustafa AM, Quesille-Villalobos A, Riquelme-Neira R, Alcalde-Rico M, Hanson B, Carvajal LP, Rincón S, Reyes J, Lam M, Calderon JF, Araos R, García P, Arias CA, Munita JM. Martínez JRW, et al. Among authors: rivas l. Microbiol Spectr. 2023 Aug 17;11(4):e0535122. doi: 10.1128/spectrum.05351-22. Epub 2023 Jun 20. Microbiol Spectr. 2023. PMID: 37338398 Free PMC article.
401 results